JYB1904, A Novel Recombinant Humanized Half-Life Extended Anti-IgE Monoclonal Antibody for Chronic Spontaneous Urticaria(CSU): Week 16 Interim Analysis Results of a Phase 2 Study versus Omalizumab
Fields of Study & Subjects
Urticaria and Related Conditions
Mast cells and histamine
Food Allergy and Anaphylaxis Research
Publication details
- Journal / source
- Journal of Allergy and Clinical Immunology
- Volume
- 157
- Issue
- 2
- Pages
- AB429–AB429
- Publication date
- 1 February 2026
- Language
- EN